Page last updated: 2024-11-07

xanthommatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Xanthommatin is a red-brown pigment found in various organisms, including insects, fungi, and bacteria. It is synthesized from the amino acid tryptophan through a complex pathway involving several enzymes. Xanthommatin is known to have various biological effects, including antioxidant, antimicrobial, and cytotoxic activities. Its antioxidant properties are attributed to its ability to scavenge reactive oxygen species, while its antimicrobial activity is related to its ability to inhibit bacterial growth. Xanthommatin is also known to be involved in the pigmentation of insect cuticles and has been implicated in insect immunity and defense mechanisms. The study of xanthommatin is important to understand its role in various biological processes and its potential applications in medicine, agriculture, and other fields. Research on xanthommatin aims to elucidate its biosynthesis pathway, its molecular mechanisms of action, and its potential therapeutic uses.'

Cross-References

ID SourceID
PubMed CID98312
CHEBI ID16550
SCHEMBL ID4576639
SCHEMBL ID20863778
MeSH IDM0043664

Synonyms (16)

Synonym
11-(3-amino-3-carboxypropanoyl)-1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylic acid
CHEBI:16550
nsc100849
xanthommatin ,
nsc-100849
521-58-4
C01969
xanthomattin
5h-pyrido(3,2-a)phenoxazine-11-butanoic acid, alpha-amino-3-carboxy-1-hydroxy-gamma,5-dioxo- (van)
nsc 100849
SCHEMBL4576639
Q22911784
SCHEMBL20863778
11-(3-amino-3-carboxypropanoyl)-1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylic acid
alpha-amino-3-carboxy-1-hydroxy-gamma,5-dioxo-5h-pyrido[3,2-a]phenoxazine-11-butanoic acid
DTXSID601131062
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthommatins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (46.67)18.7374
1990's7 (23.33)18.2507
2000's3 (10.00)29.6817
2010's4 (13.33)24.3611
2020's2 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.62 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]